Literature DB >> 17665217

Novel Robinow syndrome causing mutations in the proximal region of the frizzled-like domain of ROR2 are retained in the endoplasmic reticulum.

Bassam R Ali1, Steve Jeffery, Neha Patel, Lorna E Tinworth, Nagwa Meguid, Michael A Patton, Ali R Afzal.   

Abstract

ROR2 is a member of the cell surface receptor tyrosine kinase (RTKs) family of proteins and is involved in the developmental morphogenesis of the skeletal, cardiovascular and genital systems. Mutations in ROR2 have been shown to cause two distinct human disorders, autosomal recessive Robinow syndrome and dominantly inherited Brachydactyly type B. The recessive form of Robinow syndrome is a disorder caused by loss-of-function mutations whereas Brachydactyly type B is a dominant disease and is presumably caused by gain-of-function mutations in the same gene. We have previously established that all the missense mutations causing Robinow syndrome in ROR2 are retained in the endoplasmic reticulum and therefore concluded that their loss of function is due to a defect in their intracellular trafficking. These mutations were in the distal portion of the frizzled-like cysteine rich domain and kringle domain. Here we report the identification of two novel mutations in the frizzled-like cysteine-rich domain of ROR2 causing Robinow syndrome. We establish the retention of the mutated proteins in the endoplasmic reticulum of HeLa cells and therefore failure to reach the plasma membrane. The clustering of Robinow-causing mutations in the extracellular frizzled-like cysteine-rich domain of ROR2 suggests a stringent requirement for the correct folding of this domain prior to export of ROR2 from the endoplasmic reticulum to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665217     DOI: 10.1007/s00439-007-0409-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

Review 1.  Traffic jam: a compendium of human diseases that affect intracellular transport processes.

Authors:  M Aridor; L A Hannan
Journal:  Traffic       Date:  2000-11       Impact factor: 6.215

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains.

Authors:  C E Dann; J C Hsieh; A Rattner; D Sharma; J Nathans; D J Leahy
Journal:  Nature       Date:  2001-07-05       Impact factor: 49.962

4.  ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome.

Authors:  Ying Chen; William P Bellamy; Miguel C Seabra; Mark C Field; Bassam R Ali
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

5.  The Wnt receptor CRD domain is also found in MuSK and related orphan receptor tyrosine kinases.

Authors:  P Masiakowski; G D Yancopoulos
Journal:  Curr Biol       Date:  1998-06-04       Impact factor: 10.834

6.  Recessive Robinow syndrome: with emphasis on endocrine functions.

Authors:  A T Soliman; A Rajab; I Alsalmi; S M Bedair
Journal:  Metabolism       Date:  1998-11       Impact factor: 8.694

7.  The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells.

Authors:  Julia Billiard; Deana S Way; Laura M Seestaller-Wehr; Robert A Moran; Annamarie Mangine; Peter V N Bodine
Journal:  Mol Endocrinol       Date:  2004-09-23

8.  Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy.

Authors:  Carmel Toomes; Helen M Bottomley; Sheila Scott; David A Mackey; Jamie E Craig; Binoy Appukuttan; J Timothy Stout; Christina J Flaxel; Kang Zhang; Graeme C M Black; Alan Fryer; Louise M Downey; Chris F Inglehearn
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

9.  Autosomal recessive Robinow syndrome.

Authors:  A S Teebi
Journal:  Am J Med Genet       Date:  1990-01

Review 10.  The Frizzled family: receptors for multiple signal transduction pathways.

Authors:  Hui-Chuan Huang; Peter S Klein
Journal:  Genome Biol       Date:  2004-06-14       Impact factor: 13.583

View more
  15 in total

1.  A ROR2 coding variant is associated with craniofacial variation in domestic pigeons.

Authors:  Elena F Boer; Hannah F Van Hollebeke; Emily T Maclary; Carson Holt; Mark Yandell; Michael D Shapiro
Journal:  Curr Biol       Date:  2021-09-21       Impact factor: 10.834

2.  Phenotypic and mutational spectrum of ROR2-related Robinow syndrome.

Authors:  Ariadne R Lima; Barbara M Ferreira; Chaofan Zhang; Angad Jolly; Haowei Du; Janson J White; Moez Dawood; Tulio C Lins; Marcela A Chiabai; Ellen van Beusekom; Mara S Cordoba; Erica C C Caldas Rosa; Hulya Kayserili; Virginia Kimonis; Erica Wu; Cecilia Mellado; Vineet Aggarwal; Antonio Richieri-Costa; Décio Brunoni; Talyta M Canó; Alexander A L Jorge; Chong A Kim; Rachel Honjo; Débora R Bertola; Raissa M Dandalo-Girardi; Yavuz Bayram; Alper Gezdirici; Elif Yilmaz-Gulec; Evren Gumus; Gülay C Yilmaz; Nobuhiko Okamoto; Hirofumi Ohashi; Zeynep Coban-Akdemir; Tadahiro Mitani; Shalini N Jhangiani; Donna M Muzny; Neysa A P Regattieri; Robert Pogue; Rinaldo W Pereira; Paulo A Otto; Richard A Gibbs; Bassam R Ali; Hans van Bokhoven; Han G Brunner; V Reid Sutton; James R Lupski; Angela M Vianna-Morgante; Claudia M B Carvalho; Juliana F Mazzeu
Journal:  Hum Mutat       Date:  2022-05-10       Impact factor: 4.700

3.  Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.

Authors:  Bassam R Ali; Huifang Xu; Nadia A Akawi; Anne John; Noushad S Karuvantevida; Ruth Langer; Lihadh Al-Gazali; Birgit Leitinger
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

4.  Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer.

Authors:  Ester Lara; Vincenzo Calvanese; Covadonga Huidobro; Agustin F Fernández; Angela Moncada-Pazos; Alvaro J Obaya; Oscar Aguilera; José Manuel González-Sancho; Laura Sánchez; Aurora Astudillo; Alberto Muñoz; Carlos López-Otín; Manel Esteller; Mario F Fraga
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

5.  Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux.

Authors:  Alistair N Hume; Jens Buttgereit; Aydah M Al-Awadhi; Sarah S Al-Suwaidi; Anne John; Michael Bader; Miguel C Seabra; Lihadh Al-Gazali; Bassam R Ali
Journal:  Hum Mol Genet       Date:  2008-10-22       Impact factor: 6.150

6.  Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.

Authors:  Bassam R Ali; Imen Ben-Rebeh; Anne John; Nadia A Akawi; Reham M Milhem; Nouf A Al-Shehhi; Mouza M Al-Ameri; Shamma A Al-Shamisi; Lihadh Al-Gazali
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

7.  Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.

Authors:  Amanda Mikels; Yasuhiro Minami; Roel Nusse
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

8.  Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome.

Authors:  Chaofan Zhang; Juliana F Mazzeu; Jesper Eisfeldt; Christopher M Grochowski; Janson White; Zeynep C Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Anna Lindstrand; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  Am J Med Genet A       Date:  2020-10-13       Impact factor: 2.802

9.  Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations.

Authors:  Alistair N Hume; Anne John; Nadia A Akawi; Aydah M Al-Awadhi; Sarah S Al-Suwaidi; Lihadh Al-Gazali; Bassam R Ali
Journal:  Mol Cell Biochem       Date:  2012-11-04       Impact factor: 3.396

10.  Identification of novel ROR2 gene mutations in Indian children with Robinow syndrome.

Authors:  Parag M Tamhankar; Lakshmi Vasudevan; Shweta Kondurkar; K Yashaswini; Sunil Kumar Agarwalla; Mohandas Nair; T V Ramkumar; Nitin Chaubal; Vasundhara Sridhar Chennuri
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.